(19)

(11)

EP 3 902 917 A2

(12)

(88) Date of publication A3: 15.10.2020 (43) Date of publication: 03.11.2021 Bulletin 2021/44 (21) Application number: 19904756.4 (22) Date of filing: 23.12.2019

(51) International Patent Classification (IPC):  C12N 15/113(2010.01) A61K 31/713(2006.01) C07K 14/705(2006.01) (52) Cooperative Patent Classification (CPC): C12N 15/1138; C12N 2310/14; C12N 2310/315; C12N 2740/16043   C-Sets: C12N 2310/321, C12N 2310/3521; C12N 2310/322, C12N 2310/3533; (86) International application number: PCT/US2019/068423 (87) International publication number: WO 2020/139866 (02.07.2020 Gazette 2020/27)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 27.12.2018 US 201862785592 P (71) Applicant: bioAffinity Technologies, Inc. San Antonio, TX 78257 (US)	(72) Inventors: REBEL, Vivienne I. San Antonio, Texas 78255 (US) ELZI, David J. San Antonio, Texas 78218 (US) BAUTA, William E. San Antonio, Texas 78230 (US) (74) Representative: Octrooibureau Los en Stigter B.V.  P.O. Box 20052 1000 HB Amsterdam 1000 HB Amsterdam (NL)